CONTEXT: Conflicting findings have been reported regarding the effect of menstrual cycle phase and sex hormones on insulin sensitivity. OBJECTIVE: The aim was to determine the pattern of insulin resistance over the menstrual cycle and whether variations in sex hormones explain these patterns. DESIGN: The BioCycle study is a longitudinal study that measured hormones at different phases of the menstrual cycle. Participants had up to eight visits per cycle; each visit was timed using fertility monitors to capture sensitive windows of hormonal changes. SETTING: The study was conducted in the general community of the University at Buffalo (Buffalo, NY). PARTICIPANTS: A total of 257 healthy, premenopausal women (age, 27±8 yr; body mass index, 24±4 kg/m2) participated in the study. MAIN OUTCOME MEASURES: We measured fasting insulin, glucose, and insulin resistance by the homeostasis model of insulin resistance (HOMA-IR). RESULTS: Significant changes in HOMA-IR were observed over the menstrual cycle; from a midfollicular phase level of 1.35, levels rose to 1.59 during the early luteal phase and decreased to 1.55 in the late-luteal phase. HOMA-IR levels primarily reflected changes in insulin and not glucose. After adjustment for age, race, cycle, and other sex hormones, HOMA-IR was positively associated with estradiol (β=0.082; P<0.001) and progesterone (β=0.025; P<0.001), and inversely associated with FSH (adjusted β=-0.040; P<0.001) and SHBG (β=-0.085; P<0.001). LH was not associated with HOMA-IR. Further adjustment for BMI weakened the association with SHBG (β=-0.057; P=0.06) but did not affect other associations. CONCLUSION: Insulin exhibited minor menstrual cycle variability. Estradiol and progesterone were positively associated with insulin resistance and should be considered in studies of insulin resistance among premenopausal women.
CONTEXT: Conflicting findings have been reported regarding the effect of menstrual cycle phase and sex hormones on insulin sensitivity. OBJECTIVE: The aim was to determine the pattern of insulin resistance over the menstrual cycle and whether variations in sex hormones explain these patterns. DESIGN: The BioCycle study is a longitudinal study that measured hormones at different phases of the menstrual cycle. Participants had up to eight visits per cycle; each visit was timed using fertility monitors to capture sensitive windows of hormonal changes. SETTING: The study was conducted in the general community of the University at Buffalo (Buffalo, NY). PARTICIPANTS: A total of 257 healthy, premenopausal women (age, 27±8 yr; body mass index, 24±4 kg/m2) participated in the study. MAIN OUTCOME MEASURES: We measured fasting insulin, glucose, and insulin resistance by the homeostasis model of insulin resistance (HOMA-IR). RESULTS: Significant changes in HOMA-IR were observed over the menstrual cycle; from a midfollicular phase level of 1.35, levels rose to 1.59 during the early luteal phase and decreased to 1.55 in the late-luteal phase. HOMA-IR levels primarily reflected changes in insulin and not glucose. After adjustment for age, race, cycle, and other sex hormones, HOMA-IR was positively associated with estradiol (β=0.082; P<0.001) and progesterone (β=0.025; P<0.001), and inversely associated with FSH (adjusted β=-0.040; P<0.001) and SHBG (β=-0.085; P<0.001). LH was not associated with HOMA-IR. Further adjustment for BMI weakened the association with SHBG (β=-0.057; P=0.06) but did not affect other associations. CONCLUSION:Insulin exhibited minor menstrual cycle variability. Estradiol and progesterone were positively associated with insulin resistance and should be considered in studies of insulin resistance among premenopausal women.
Authors: Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: Ying Zhang; Barbara V Howard; Linda D Cowan; Jeunliang Yeh; Carl F Schaefer; Robert A Wild; Wenyu Wang; Elisa T Lee Journal: Diabetes Care Date: 2002-03 Impact factor: 19.112
Authors: K L Margolis; D E Bonds; R J Rodabough; L Tinker; L S Phillips; C Allen; T Bassford; G Burke; J Torrens; B V Howard Journal: Diabetologia Date: 2004-07-14 Impact factor: 10.122
Authors: Alka M Kanaya; David Herrington; Eric Vittinghoff; Feng Lin; Deborah Grady; Vera Bittner; Jane A Cauley; Elizabeth Barrett-Connor Journal: Ann Intern Med Date: 2003-01-07 Impact factor: 25.391
Authors: Kevin R Short; Lauren V Pratt; April M Teague; Chiara Dalla Man; Claudio Cobelli Journal: Pediatr Diabetes Date: 2012-07-23 Impact factor: 4.866
Authors: Robert M Sargis; Brian A Neel; Clifton O Brock; Yuxi Lin; Allison T Hickey; Daniel A Carlton; Matthew J Brady Journal: Biochim Biophys Acta Date: 2012-02-23
Authors: Sridevi Krishnan; Karan Agrawal; Rebecca R Tryon; Lucas C Welch; William F Horn; John W Newman; Nancy L Keim Journal: Physiol Behav Date: 2018-07-18
Authors: Talia N Crawford; Andrea Y Arikawa; Mindy S Kurzer; Kathryn H Schmitz; William R Phipps Journal: Fertil Steril Date: 2015-09-16 Impact factor: 7.329
Authors: Clare A Flannery; Gina H Choe; Katherine M Cooke; Andrew G Fleming; Caitlin C Radford; Pinar H Kodaman; Michael J Jurczak; Richard G Kibbey; Hugh S Taylor Journal: J Clin Endocrinol Metab Date: 2018-08-01 Impact factor: 5.958
Authors: Melissa F Wellons; Gordon Wright Bates; Pamela J Schreiner; David S Siscovick; Barbara Sternfeld; Cora E Lewis Journal: Menopause Date: 2013-08 Impact factor: 2.953